Last Price$302.80.6%
Market Cap$17.3B
LTM Enterprise Value
$9,983.3M
5Y avg
$11.1B
Medical - Healthcare Plans industry
median
$19.3B
Stock quality & Intrinsic value
6/10
0.4% undervalued
Molina Healthcare, Inc. Enterprise Value
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enterprise Value | $408.5M | $497.8M | $568.7M | $110.2M | $157.5M | $412.8M | $405.4M | $422.8M | $732.2M | $1,077.9M | $705.8M | $54.2M | $954.1M | $3,933.9M | $5,473.1M | $9,334.9M | $13.7B | $13.7B | $13.7B | $9,983.3M |
Overvalued or undervalued?
Check the intrinsic value for MOH
and see if it's the right time to invest.
Molina Healthcare, Inc. (MOH) Enterprise Value comparison analysis
General
LTM Enterprise Value
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Molina Healthcare, Inc.MOH
$15.8B
19.3%
9.2%
2.9%
Median Peer Set
$26.9B
7.2%
(11.9%)
1.1%
UnitedHealth Group IncorporatedUNH
$411.4B
8.9%
(35.7%)
3.6%
CVS Health CorporationCVS
$154.3B
4.2%
(43.6%)
1.2%
Cigna CorporationCI
$110.9B
8.4%
(18.9%)
2.6%
Elevance Health Inc.ELV
$84.4B
3.2%
(0.0%)
3.4%
Centene CorporationCNC
$30.9B
5.9%
27.4%
2.0%
Humana Inc.HUM
$22.8B
10.7%
(50.1%)
1.0%
Alignment Healthcare, Inc.ALHC
$2,679.9M
27.2%
(4.8%)
(8.1%)
Oscar Health, Inc.OSCR
$1,851.2M
56.5%
N/A
0.3%
Clover Health Investments, Corp.CLOV
$1,650.0M
(41.5%)
(31.3%)
(10.5%)
Bright Health Group, Inc.BHG
$342.3M
(51.9%)
86.2%
(103.4%)
MOH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,650.1 40.4% | 2,005.0 21.5% | 2,492.5 24.3% | 3,112.4 24.9% | 3,669.4 17.9% | 4,086.0 11.4% | 4,769.9 16.7% | 6,028.8 26.4% | 6,588.9 9.3% | 9,666.6 46.7% | 14,072.0 45.6% | 17,711.0 25.9% | 19,883.0 12.3% | 18,890.0 (5.0%) | 16,829.0 (10.9%) | 19,423.0 15.4% | 27,771.0 43.0% | 31,974.0 15.1% | 34,072.0 6.6% | 40,650.0 19.3% |
| Cost of Goods Sold (COGS) | 1,424.9 | 1,678.7 | 2,080.1 | 2,621.3 | 3,176.2 | 3,449.5 | 4,004.0 | 5,397.0 | 5,713.6 | 8,616.1 | 12,434.0 | 15,941.0 | 18,003.0 | 16,266.0 | 14,394.0 | 16,746.0 | 24,491.0 | 28,048.0 | 29,738.0 | 0.0 |
% margin | 225.2 13.6% | 326.3 16.3% | 412.4 16.5% | 491.1 15.8% | 493.1 13.4% | 636.5 15.6% | 766.0 16.1% | 631.8 10.5% | 875.3 13.3% | 1,050.5 10.9% | 1,638.0 11.6% | 1,770.0 10.0% | 1,880.0 9.5% | 2,624.0 13.9% | 2,435.0 14.5% | 2,677.0 13.8% | 3,280.0 11.8% | 3,926.0 12.3% | 4,334.0 12.7% | 40,650.0 100.0% |
| Operating Expenses | 179.4 | 250.5 | 314.0 | 378.4 | 437.3 | 531.5 | 621.2 | 596.3 | 738.7 | 857.6 | 1,251.0 | 1,532.0 | 1,731.0 | 1,432.0 | 1,385.0 | 1,599.0 | 2,260.0 | 2,545.0 | 2,761.0 | 38,943.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 163.3 | 229.1 | 285.3 | 344.8 | 399.1 | 346.0 | 415.9 | 532.6 | 666.0 | 764.7 | 1,147.0 | 1,393.0 | 1,594.0 | 1,333.0 | 1,296.0 | 1,480.0 | 2,068.0 | 2,311.0 | 2,462.0 | 2,743.0 |
% margin | 45.8 2.8% | 75.8 3.8% | 98.3 3.9% | 112.6 3.6% | 57.4 1.6% | 105.0 2.6% | 80.2 1.7% | 35.5 0.6% | 136.6 2.1% | 192.9 2.0% | 387.0 2.8% | 238.0 1.3% | (555.0) (2.8%) | 1,131.0 6.0% | 1,044.0 6.2% | 1,078.0 5.6% | 1,020.0 3.7% | 1,173.0 3.7% | 1,573.0 4.6% | 1,707.0 4.2% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.0 | 102.0 | 120.0 | 110.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 4.6 | 8.7 | 13.8 | 15.5 | 15.5 | 16.8 | 52.1 | 56.8 | 67.0 | 101.0 | 118.0 | 115.0 | 87.0 | 102.0 | 120.0 | 110.0 | 109.0 | 118.0 |
| Pre-tax Income | 43.9 | 73.5 | 93.7 | 103.9 | 43.6 | 89.5 | 64.7 | 19.1 | 81.1 | 135.3 | 322.0 | 137.0 | (612.0) | 999.0 | 972.0 | 961.0 | 875.0 | 1,063.0 | 1,464.0 | 1,589.0 |
% effective tax rate | 16.3 37.1% | 27.7 37.8% | 35.4 37.7% | 41.5 39.9% | 12.7 29.2% | 34.5 38.6% | 43.8 67.8% | 9.3 48.6% | 36.3 44.8% | 72.7 53.8% | 179.0 55.6% | 129.0 94.2% | (100.0) 16.3% | 292.0 29.2% | 235.0 24.2% | 288.0 30.0% | 216.0 24.7% | 271.0 25.5% | 373.0 25.5% | 410.0 25.8% |
% margin | 27.6 1.7% | 45.7 2.3% | 58.3 2.3% | 62.4 2.0% | 30.9 0.8% | 55.0 1.3% | 20.8 0.4% | 9.8 0.2% | 52.9 0.8% | 62.2 0.6% | 143.0 1.0% | 8.0 0.0% | (512.0) (2.6%) | 707.0 3.7% | 737.0 4.4% | 673.0 3.5% | 659.0 2.4% | 792.0 2.5% | 1,091.0 3.2% | 1,179.0 2.9% |
| EPS | 0.67 | 1.09 | 1.37 | 1.50 | 0.79 | 1.34 | 0.45 | 0.21 | 1.16 | 1.33 | 2.75 | 0.93 | (9.14) | 10.61 | 11.85 | 11.41 | 11.40 | 13.70 | 18.71 | 20.43 |
| Diluted EPS | 0.65 | 1.08 | 1.37 | 1.50 | 0.79 | 1.32 | 0.45 | 0.21 | 1.13 | 1.29 | 2.58 | 0.92 | (9.14) | 10.55 | 11.48 | 11.24 | 11.25 | 13.54 | 18.78 | 20.43 |
% margin | 60.9 3.7% | 97.3 4.9% | 126.3 5.1% | 146.3 4.7% | 94.0 2.6% | 165.8 4.1% | 210.2 4.4% | 118.3 2.0% | 214.1 3.2% | 332.7 3.4% | 514.0 3.7% | 488.0 2.8% | (316.0) (1.6%) | 1,241.0 6.6% | 1,148.0 6.8% | 1,151.0 5.9% | 1,126.0 4.1% | 1,349.0 4.2% | 1,744.0 5.1% | 1,893.0 4.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Molina Healthcare, Inc.'s Enterprise Value?
As of today, Molina Healthcare, Inc.'s last 12-month Enterprise Value is $9,983.3M, based on the financial report for Dec 30, 2024 (Q4’2024).
2) What is Molina Healthcare, Inc.'s Enterprise Value growth rate?
Over the last year, Molina Healthcare, Inc.'s Enterprise Value growth was (26.9%). The average annual Enterprise Value growth rates for Molina Healthcare, Inc. have been (2.6%) over the past three years, 12.8% over the past five years.
3) Is Molina Healthcare, Inc.'s Enterprise Value growth rate Good?
Over the last year, Molina Healthcare, Inc.'s Enterprise Value growth was (26.9%), which is lower than industry growth of 0.0%. It indicates that Molina Healthcare, Inc.'s Enterprise Value growth is Bad.